| Indicators | Browse All

Profusa, Inc. (PFSA)

Healthcare | Medical Devices | Berkeley, United States | NasdaqCM
2.21 USD +0.09 (4.245%) ⇧ (July 13, 2026, 4 p.m. EDT)
After hours: 2.13 -0.08 (-0.080%) ⇩ (July 13, 2026, 7:58 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:41 a.m. EDT

The immediate outlook is severely compromised by a catastrophic collapse in share price, which has erased nearly 99% of the company's value since mid-July. While the recent surge to $2.81 followed by a drop to $2.12 suggests some volatility, the underlying reality is a company facing existential threats: negative book value of nearly $300 per share, massive debt obligations exceeding $1.2 billion against negligible cash, and a current ratio of 0.023 indicating imminent insolvency. The recent news of a 1-for-75 reverse split and a transfer to the Nasdaq Capital Market are desperate compliance maneuvers rather than signs of recovery. Fundamentally, the business is generating significant free cash outflows and has no earnings, making any long-term investment thesis untenable. There is no dividend to provide income, and the statistical models correctly flag the situation as highly unreliable due to the extreme price noise and structural breakdown.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.376824
MSTL0.635499
AutoETS0.641998
AutoARIMA0.642005

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 20%
H-stat 121.54
Ljung-Box p 0.000
Jarque-Bera p 0.030
Excess Kurtosis -0.33
Attribute Value
Sector Healthcare
Market Cap 1,171,300
Beta 0.44
Website https://profusa.com

Info Dump

Attribute Value
52 Week Change -0.99944025
Address1 626 Bancroft Way
Address2 Suite A
All Time High 10,312.5
All Time Low 1.93
Ask 2.23
Ask Size 1
Average Daily Volume10 Day 246,012
Average Daily Volume3 Month 156,271
Average Volume 156,271
Average Volume10Days 246,012
Beta 0.437
Bid 2.06
Bid Size 1
Book Value -296.194
City Berkeley
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.21
Current Ratio 0.023
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.4
Day Low 1.915
Display Name Profusa
Ebitda Margins 0.0
Enterprise Value 12,573,968
Eps Trailing Twelve Months -384.07
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 7.6639
Fifty Day Average Change -5.4539
Fifty Day Average Change Percent -0.71163505
Fifty Two Week Change Percent -99.94402
Fifty Two Week High 4,500.0
Fifty Two Week High Change -4,497.79
Fifty Two Week High Change Percent -0.9995089
Fifty Two Week Low 1.915
Fifty Two Week Low Change 0.29500008
Fifty Two Week Low Change Percent 0.15404704
Fifty Two Week Range 1.915 - 4500.0
Financial Currency USD
First Trade Date Milliseconds 1,752,240,600,000
Float Shares 181,855
Free Cashflow -13,868,750
Full Exchange Name NasdaqCM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Implied Shares Outstanding 530,000
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,025-07-14
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,783,382,400
Last Split Factor 1:25
Long Business Summary Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Long Name Profusa, Inc.
Market us_market
Market Cap 1,171,300
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_141932876
Most Recent Quarter 1,774,915,200
Net Income To Common -36,563,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,113,000
Open 2.03
Operating Cashflow -18,287,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 925 997 6925
Post Market Change -0.079600096
Post Market Change Percent -3.6018143
Post Market Price 2.1304
Post Market Time 1,783,987,101
Previous Close 2.12
Price Hint 4
Price To Book -0.007461326
Profit Margins 0.0
Quick Ratio 0.013
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0900002
Regular Market Change Percent 4.24529
Regular Market Day High 2.4
Regular Market Day Low 1.915
Regular Market Day Range 1.915 - 2.4
Regular Market Open 2.03
Regular Market Previous Close 2.12
Regular Market Price 2.21
Regular Market Time 1,783,972,800
Regular Market Volume 297,604
Return On Assets -9.231891
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 530,000
Shares Percent Shares Out 0.0504
Shares Short 9,399
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 11,532
Short Name Profusa, Inc.
Short Percent Of Float 0.0508
Short Ratio 0.03
Source Interval 15
State CA
Symbol PFSA
Total Cash 375,000
Total Cash Per Share 2.012
Total Debt 12,537,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -384.07
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 173.86336
Two Hundred Day Average Change -171.65335
Two Hundred Day Average Change Percent -0.98728883
Type Disp Equity
Volume 297,604
Website https://profusa.com
Zip 94,710